Results 281 to 290 of about 163,730 (308)
Some of the next articles are maybe not open access.
Current Opinion in Immunology, 2002
Increasingly, data from distinct experimental systems show that immunity can be activated to prevent tumors. The rationale for prevention is strong because, in that setting, one deals with an immune system that is neither impaired by tumor- and treatment-induced suppression nor tolerant to tumor-associated antigens that have been encountered in the ...
Olivera J, Finn, Guido, Forni
openaire +2 more sources
Increasingly, data from distinct experimental systems show that immunity can be activated to prevent tumors. The rationale for prevention is strong because, in that setting, one deals with an immune system that is neither impaired by tumor- and treatment-induced suppression nor tolerant to tumor-associated antigens that have been encountered in the ...
Olivera J, Finn, Guido, Forni
openaire +2 more sources
A vaccine for colorectral cancer
Trends in Immunology, 2001Colorectal cancer is one of the four most prevalent cancers worldwide. It is estimated that in the USA this year, 135 400 people will be diagnosed with and 56 700 people will die from this disease. Life expectancy for stage IV disease, which might affect as many as 50 000 individuals in the USA this year, is seven and a half months.At the 37th Annual ...
openaire +2 more sources
2016
Cancer is one of the major leading death causes of diseases. Prevention and treatment of cancer is an important way to decrease the incidence of tumorigenesis and prolong patients' lives. Subversive achievements on cancer immunotherapy have recently been paid much attention after many failures in basic and clinical researches. Based on deep analysis of
Zhenlong, Ye +3 more
openaire +2 more sources
Cancer is one of the major leading death causes of diseases. Prevention and treatment of cancer is an important way to decrease the incidence of tumorigenesis and prolong patients' lives. Subversive achievements on cancer immunotherapy have recently been paid much attention after many failures in basic and clinical researches. Based on deep analysis of
Zhenlong, Ye +3 more
openaire +2 more sources
Immunosenescence and cancer vaccines
Cancer Immunology, Immunotherapy, 2009Experimental and clinical data demonstrate that ageing is associated with the gradual deterioration of the immune system, generally referred to as immunosenescence. Age-related immune dysfunction may have an impact not only on the incidence of cancer, but also on the preventive and therapeutic approaches, which are based on immune system activation ...
openaire +2 more sources
Current Opinion in Immunology, 2006
The immunological bases of current approaches to therapeutic cancer vaccination (or 'vacci-treatment') have been established for a decade or longer. The new developments lie mostly in the lessons learnt from clinical testing of these approaches. Three lessons are particularly worthy of note.
openaire +2 more sources
The immunological bases of current approaches to therapeutic cancer vaccination (or 'vacci-treatment') have been established for a decade or longer. The new developments lie mostly in the lessons learnt from clinical testing of these approaches. Three lessons are particularly worthy of note.
openaire +2 more sources
COVID-19 vaccines in patients with cancer: immunogenicity, efficacy and safety
Nature Reviews Clinical Oncology, 2022Annika Fendler +2 more
exaly
Identification of neoantigens for individualized therapeutic cancer vaccines
Nature Reviews Drug Discovery, 2022Franziska Lang +2 more
exaly
Challenges in developing personalized neoantigen cancer vaccines
Nature Reviews Immunology, 2023Peter D Katsikis +2 more
exaly
Metal-based nano-vaccines for cancer immunotherapy
Coordination Chemistry Reviews, 2022Jiexin Li, Yumiao Zhang
exaly